Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey

People with Down syndrome (DS) are one of the highest risk groups for mortality associated with COVID-19, but outcomes may differ across countries due to different co-morbidity profiles, exposures, and societal practices, which could have implications for disease management. This study is designed t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of global health 2022-08, Vol.12, p.05035, Article 05035
Hauptverfasser:	Pinku, Halder, Hüls, Anke, Feany, Patrick T, Baumer, Nicole, Dierssen, Mara, Bargagna, Stefania, Costa, Alberto Cs, Chicoine, Brian A, Rebillat, Anne-Sophie, Sgandurra, Giuseppina, Valentini, Diletta, Rohrer, R Tilman, Levin, Johannes, Lakhanpaul, Monica, Carfì, Angelo, Sherman, Stephanie L, Strydom, Andre, Ghosh, Sujay
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 - therapy Developed Countries Down Syndrome - epidemiology Down Syndrome - therapy Humans Income India - epidemiology Research Theme 1: COVID-19 Pandemic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!